Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Bridget Webb

Nurse Practitioner, Obstetrics & Gynecology Overland Park, KS Nurse Practitioner

NPI 1801981675 CMS profile 10593857

10600 Quivira Rd, Suite 110, Overland Park, KS 66215

Open in the dashboard

General payments

$5,407

353 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Bridget Webb of Overland Park, KS is reported in the CMS Open Payments database as having received $5,407 across 353 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Nurse Practitioner, Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $395 21
2024 General $618 46
2023 General $1,072 74
2022 General $1,763 121
2021 General $1,560 91

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bridget Webb
  • Nurse Practitioner, Obstetrics & Gynecology median
  • Middle half of Nurse Practitioner, Obstetrics & Gynecology
  • National median

In program year 2025, general payments to Bridget Webb were reported at $395. Among 1,030 Nurse Practitioner, Obstetrics & Gynecology profiles paid that year, the median was $151 and the middle half received between $51 and $371.

Show as a table
Year Bridget Webb Nurse Practitioner, Obstetrics & Gynecology median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $1,560 $135 $40–$338 $132
2022 $1,763 $143 $45–$386 $149
2023 $1,072 $153 $54–$411 $160
2024 $618 $140 $45–$326 $164
2025 $395 $151 $51–$371 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $2,376 148 payments
  2. Pfizer Inc. $655 52 payments
  3. Mayne Pharma Inc. $426 30 payments
  4. Sumitomo Pharma America, Inc. $277 16 payments
  5. Eisai Inc. $167 10 payments
  6. Urovant Sciences Inc $158 11 payments
  7. Avion Pharmaceuticals $157 9 payments
  8. Biohaven Pharmaceutical Holding Company Ltd. $142 11 payments
  9. Myovant Sciences Inc. $139 9 payments
  10. Lilly USA, LLC $135 8 payments
  11. Other $775 49 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $5,407 353 payments
Products named General payments · program years 2021–2025
  1. UBRELVY $945 70 payments
  2. LO LOESTRIN FE $612 29 payments
  3. PREMARIN $451 36 payments
  4. NURTEC ODT $441 38 payments
  5. QULIPTA $403 27 payments
  6. ORILISSA $375 17 payments
  7. ORIAHNN $366 16 payments
  8. MYFEMBREE $354 28 payments
  9. LINZESS $327 18 payments
  10. GEMTESA $321 21 payments
  11. Other $3,000 192 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

353 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Obstetrics & Gynecology in Kansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record